Adar Silverstein - Onconova Therapeutics Sr Devel
| ONTXDelisted Stock | USD 1.02 0.04 3.77% |
Insider
Adar Silverstein is Sr Devel of Onconova Therapeutics
| Phone | 267 759 3680 |
| Web | https://www.onconova.com |
Onconova Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.3807) % which means that it has lost $0.3807 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.843) %, meaning that it created substantial loss on money invested by shareholders. Onconova Therapeutics' management efficiency ratios could be used to measure how well Onconova Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Louis Ploth | Moleculin Biotech | 70 | |
| Uday Kompella | Ocugen Inc | 57 | |
| Waldemar Priebe | Moleculin Biotech | N/A | |
| CPA JD | Jaguar Animal Health | 60 | |
| CPA CPA | Ocugen Inc | 47 | |
| David Sesin | Jaguar Animal Health | N/A | |
| MBA MBA | Adial Pharmaceuticals | 46 | |
| Dr DVM | Ibio Inc | 54 | |
| CPA MBA | Vaxart Inc | 72 | |
| Alan MacKenzie | Bio Path Holdings | N/A | |
| CPA CPA | Tonix Pharmaceuticals Holding | 50 | |
| Tiffany MBA | Ocugen Inc | N/A | |
| Aidan Curran | Pulmatrix | N/A | |
| Melissa Berquist | Ibio Inc | N/A | |
| Margaret MD | Pulmatrix | 67 | |
| Catherine Fratila | Adial Pharmaceuticals | N/A | |
| FACP MD | Moleculin Biotech | 70 | |
| Brant Biehn | Vaxart Inc | N/A | |
| MBA CMA | Pulmatrix | 69 | |
| Randy Maddux | Ibio Inc | 63 | |
| Stephen Kilmer | Ibio Inc | N/A | |
Management Performance
| Return On Equity | -0.84 | |||
| Return On Asset | -0.38 |
Onconova Therapeutics Leadership Team
Elected by the shareholders, the Onconova Therapeutics' board of directors comprises two types of representatives: Onconova Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Onconova. The board's role is to monitor Onconova Therapeutics' management team and ensure that shareholders' interests are well served. Onconova Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Onconova Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark CPA, CFO COO | ||
| Victor MD, Chief Officer | ||
| Steven MD, President CEO | ||
| Mark MD, Chief Officer | ||
| Adar Silverstein, Sr Devel |
Onconova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Onconova Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.84 | |||
| Return On Asset | -0.38 | |||
| Operating Margin | (89.28) % | |||
| Current Valuation | (4.56 M) | |||
| Shares Outstanding | 21 M | |||
| Shares Owned By Insiders | 0.77 % | |||
| Shares Owned By Institutions | 7.95 % | |||
| Number Of Shares Shorted | 20.7 K | |||
| Price To Earning | (0.87) X | |||
| Price To Book | 1.43 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Onconova Stock
If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |